Related Experiment Video

Updated: Jul 13, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway

Yan Li1, Wei Yin, Xia Wang

  • 1Department of Pharmacology, Zhong-shan Medical College, Sun Yat-Sen University, Guangzhou 510089, China.

Proceedings of the National Academy of Sciences of the United States of America
|August 8, 2007
PubMed

Insights

Cholera toxin induces differentiation in malignant gliomas by increasing cAMP levels. This finding suggests cholera toxin

Area of Science:

  • Oncology
  • Cell Biology
  • Neuroscience

Background:

  • Malignant gliomas are a significant cause of cancer mortality globally.
  • Effective chemoprevention strategies for gliomas are limited and underexplored.

Purpose of the Study:

  • To investigate the potential of cholera toxin as an agent for inducing differentiation in malignant gliomas.
  • To elucidate the cellular mechanisms underlying cholera toxin-induced glioma differentiation.

Main Methods:

  • In vitro studies using rat C6 and primary human glioma cells.
  • Assessment of morphological changes, protein expression (GFAP, Ki-67, cyclins, Cdks, p21, p27).
  • Analysis of cell cycle progression and cAMP-dependent protein kinase A (PKA) pathway involvement.

Main Results:

  • Cholera toxin induced differentiation in glioma cells, characterized by morphological changes and altered protein expression.
  • Inhibition of proliferation and cell cycle arrest in G1 phase were observed.
  • Cholera toxin modulated key cell cycle regulators (cyclin D1, Cdk2, p21, p27) and activated the PKA/CREB pathway.

Conclusions:

  • Cholera toxin shows promise as a potential therapeutic agent for glioma differentiation therapy.
  • The PKA/cAMP-responsive element binding protein (CREB) pathway is crucial for cholera toxin-mediated glioma differentiation.

More Related Videos

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

Related Concept Videos

Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...